SanaClis sharing advanced CTS insights to Evolution Summit


SanaClis sharing advanced CTS insights to Evolution Summit


Sanaclis Logo100x141

Press Release | SanaClis s.r.o.

NOVEMBER 15, 2017

Bratislava, Slovakia: – Award-winning full service CRO SanaClis is among the invitees to the exclusive annual Evolution Summit in Montreux, Switzerland 13-15 November 2017.

The Evolution Summit is an invitation-only event held behind closed doors to provide a distinctively intimate and interactive environment for senior decision makers from the pharma industry to meet innovation solutions providers in the demanding world of clinical trials.

CRO alliances

At Evolution 2017, SanaClis leaders help explore a number of urgent issues for the clinical trials community. These include: sustaining in-house intelligence and external CRO alliances, the Digital Health Revolution, leveraging data for new drug development strategies, decoding regulatory guidelines, more effective co-operations on R&D management, pioneering novel parameters in neurodegenerative (CNS) disease and executing clinical trials in emerging markets.

“We have thoughts and insights on hot topics like these that we look forward to sharing in Montreux,’ said SanaClis Managing Partner and Member of the Board, Alexander Fetkovsky, who lead the SanaClis presence in Montreux.

Full service CRO

“As a full service clinical research organization, SanaClis defines the Evolution summit as an ideal forum to establish even deeper and more productive relationships with potential business partners,” said Mr. Fetkovsky.

“This is a highly expert gathering of a global network of Pharma and Biotech decision makers within Clinical Operations, Clinical Development, Supply Chain and Data Management and other professionals involved in clinical trials allows us to identify emerging pharma trends,” Mr. Fetkovsky added.

Advanced IMP/CTS

SanaClis uses Evolution’s interactive format, including think tanks and panel discussions to show how its own full service clinical trial supplies (CTS) solutions help to deal with emerging issues. It will also have a tabletop display that will showcase its advanced software dedicated to IMP management that provides direct client access to IMP stock and movements in warehouses, allowing visitors to test online tracking of IMP storage conditions for themselves.

“Our aim is to propose the best possible “cost-quality” solution by using our own resources, own facilities and partnership synergies,” Mr. Fetkovsky explained.

“We can also help open the door to EU for non-EU companies as well as, working the other way, opening up opportunities in post-Soviet countries such as Russia, Ukraine, Belarus, and Georgia while using fewer vendors and leaner structure.” he added.

About SanaClis

SanaClis is a Slovakian-headquartered full service European CRO supporting pharma and biotech companies for more than 15 years covering full cycle of Phase I-IV, bioequivalence clinical trials under one roof. In addition to classical CRO services such as regulatory, clinical monitoring and project management, data management and biostatistics it also offers IMP management services in Central and Eastern Europe via its network of GxP-compliant warehouses.

In 2012, SanaClis s.r.o. was rated positively by reputable business agency Creditreform and for 2013, 2014, 2015 and 2016 was certified with the AA rating “High creditworthiness” by Bisnode rating agency. SanaClis has earned its place on Nice Insight’s survey of Top Ten lists of Clinical Research Organizations (CROs) for 2015, based on customer perceptions of quality.

SanaClis’ Founder and Chair of the Board, Dr. Natalia Fetkovska, joined the ranks of the winners of BW’s annual CEO Awards 2016 in recognition for her work in taking SanaClis to become leading CRO in Central and Eastern Europe, recognizes for its reliability and professionalism.

This is the first time a Slovakian-headquartered CRO has finished among the leaders in CRO industry, reflecting intensive investments and quality assurance measures. In 2015, SanaClis was awarded with the CRO Leadership Award in the category Reliability. Moreover in 2015 SanaClis was awarded for Excellence in Drug Development – Europe & Best for Clinical Trials 2015. In 2016, SanaClis was rewarded with Award for Best Drug Development CRO 2016 – Europe & Award for Excellence in Clinical Trial Monitoring – Europe. Afterwards SanaClis was recognized by CV magazine and received Health Tech & Pharma Innovation Awards 2016 in the category Software.

About Evolution Summit 2017

Founded in 2002, The Evolution Summit aims to unite pharmaceutical companies with innovative solutions. It provides qualified decision makers with a distinctively interactive forum for that combines business insights, one on one meetings and networking opportunities.

The 15th annual Evolution Summit 2017 is a three-day event opening November 13 at the Fairmont Le Montreux Palace, Montreux, Switzerland.

This is an invitation-only event, taking place behind closed doors, to provide an intimate environment for a focused discussion of key new drivers shaping drug development.

Marcus Evans organizes the event with more information at: http://www.evolutionsummit.com

Media Contact

Svitlana Udubkova, BD manager, SanaClis
Tel: +42 191 811 6271
Email: svitlana.udubkova@sanaclis.eu

Resources

Click on SanaClis at Evolution Annual Summit, Montreux for more information.
Click on SanaClis to contact the company directly.
Follow SanaClis at Twitter or LinkedIn.


Supplier Information
Supplier: SanaClis s.r.o.
Address: Stare Grunty 130, 841 04, Bratislava, Slovakia
Tel: +421 917 820 310
Fax: +421 264 28 76 25
Website: http://www.sanaclis.eu/


Comments are closed.